Symbol | Company | Weighting |
---|---|---|
NTRA | NATERA INC | 4.36% |
NVO | NOVO NORDISK A/S | 3.72% |
LLY | ELI LILLY CORP | 3.29% |
BSX | BOSTON SCIENTIFIC | 2.90% |
CYTK | CYTOKINETICS INC | 2.77% |
CERE | CEREVEL THERAPEUTICS HLD | 2.48% |
SYK | STRYKER CORP | 2.47% |
ITCI | INTRA-CELLULAR THERAPIES USD | 2.41% |
HCA | HCA HOLDINGS INC | 2.34% |
PCVX | VAXCYTE INC | 2.33% |
VRTX | VERTEX PHARMACEUTICALS INC | 2.26% |
TWST | TWIST BIOSCIENCE CORP USD 0.00001 | 2.11% |
AVTR | AVANTOR, INC. | 2.08% |
DXCM | DEXCOM INC | 2.03% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.97% |
IDXX | IDEXX LABS CORP | 1.96% |
XENE | XENON PHARMACEUTICALS | 1.95% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.95% |
LNTH | LANTHEUS HOLDINGS INC | 1.93% |
IQV | IQVIA HOLDINGS INC | 1.91% |
SRPT | SAREPTA THERAPEUTICS INC | 1.90% |
MOH | MOLINA HEALTHCARE INC | 1.88% |
AZN | ASTRAZENECA PLC-ADR | 1.86% |
CI | THE CIGNA GROUP | 1.80% |
ZTS | ZOETIS INC | 1.80% |
ZBH | ZIMMER BIOMET HOLDINGS INC | 1.79% |
OPCH | OPTION CARE HEALTH, INC. | 1.78% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.76% |
DHR | DANAHER CORP | 1.70% |
APLS | APELLIS PHARMACEUTICALS INC | 1.67% |
UNH | UNITEDHEALTH GROUP INC | 1.65% |
CRL | CHARLES RIVER LABORATORIES INT INC | 1.63% |
MASI | MASIMO CORP | 1.62% |
WAT | WATERS CORP | 1.58% |
AMGN | AMGEN CORP | 1.54% |
ADUS | ADDUS HOMECARE CORPORATION | 1.52% |
UTHR | UNITED THERAPEUTICS CORPS | 1.48% |
ACHC | ACADIA HEALTHCARE CO INC | 1.46% |
JNJ | JOHNSON & JOHNSON | 1.43% |
RMD | RESMED INC | 1.35% |
TECH | BIO-TECHNE CORPORATION | 1.30% |
RVTY | REVVITY INC | 1.28% |
GMED | GLOBUS MEDICAL INC CLASS A | 1.26% |
BIO | BIO-RAD LABORATORIES INC | 1.25% |
JAZZ | JAZZ PHARMACEUTICALS PLC | 1.23% |
ALNY | ALNYLAM PHARMACEUTICALS INC. | 1.14% |
BIIB | BIOGEN INC | 1.14% |
XNCR | XENCOR INC. | 1.11% |
ARVN | ARVINAS INC USD | 1.07% |
HUM | HUMANA INC | 1.07% |
ILMN | ILLUMINA INC | 0.98% |
PODD | INSULET CORP | 0.94% |
MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. (CLASS A) | 0.90% |
DNLI | DENALI THERAPEUTICS INC. | 0.88% |
NTLA | INTELLIA THERAPEUTICS INC | 0.74% |
BCRX | BIOCRYST PHARMACEUTICALS INC | 0.58% |
ABCL | ABCELLERA BIOLOGICS INC NPV | 0.47% |
VLTO | VERALTO CORP | 0.21% |
MRTXES | CONTRA MIRATI THERAPEU + NPV | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.